SOURCE: Wall Street Active

January 03, 2013 08:20 ET

Are Those Stocks, ABT, HEB, SKUL and TZYM, Oversold?

LONDON--(Marketwire - Jan 3, 2013) - Wall Street Active pro-traders will be assisting investors today on ABT, HEB, SKUL and TZYM, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity, as our trading experts can show how to turn $5,000 into $35,000.

Abbott Laboratories (NYSE: ABT) closed at $32.05 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in ABT by signing up to the link below. 

http://www.wallstreetactive.com/register.php

Hemispherx Biopharma Inc. (NYSE MKT: HEB) closed at $0.25 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in HEB by signing up to the link below. 

http://www.wallstreetactive.com/register.php

Skullcandy Inc. (NASDAQ: SKUL) closed at $6.80 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in SKUL by signing up to the link below. 

http://www.wallstreetactive.com/register.php

Tranzyme Inc. (NASDAQ: TZYM) closed at $0.51 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in TZYM by signing up to the link below. 

http://www.wallstreetactive.com/register.php

Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Information